ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302035 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302035; 2) Community: the network communities that were significantly associated with the response to NSC 302035; 3) Molecule: the relationships between components within communities and NSC 302035; 4) MDR: the compounds that were significantly associated with the NSC 302035.

NSC Compound Enrichment Correlation
NSC 748715 Null 0.0282295482823984 0.19747159
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0282295482823984 0.75037144
NSC 758881 Orlistat (USAN) 0.0282295482823984 0.19212869
NSC 104942 EUPAROTIN 0.0282295482823987 0.66680601
NSC 114512 Null 0.0282295482823987 0.5442051
NSC 13318 Null 0.0282295482823987 0.51895918
NSC 15309 2,5-Cyclohexadiene-1,4-dione, 2,5-dimethyl- (9CI) 0.0282295482823987 0.49736269
NSC 189793 Streptovaricin complex, fraction a 0.0282295482823987 0.24884594
NSC 241494 Null 0.0282295482823987 0.44908553
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0282295482823987 0.071479065
Total:95  Current:72    [First] [Prev] [Next] [Last]